Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

British American Tobacco

Anheuser-Busch InBev

DraftKings

Las Vegas Sands

Constellation Brands

AdvisorShares Vice ETF

A hot, pandemic-light summer is expected to lead to soaring investor interest in sin stocks. Here are seven of the leading vice stocks The post 7 Sin Stocks to Buy for a Hot Vax Summer appeared first on InvestorPlace.

7 Sin Stocks to Buy for a Hot Vax Summer

Dollar General

Vanguard International High Dividend Yield ETF

The stock market is near its all-time high as of my writing this article, raising questions about whether valuations make sense in the long run.

Stock Market Overvalued? 3 Hidden Gem Value Investments To Consider

Philip Morris

Vector Group

3 Tobacco Stocks to Watch for Gains in a Challenging Industry

Alerian MLP ETF

Broadmark Realty Capital Inc.

Clearway Energy

Medical Properties Trust

After 14 weeks and $1,400, the Dividend Harvesting Portfolio is generating $86.96 in estimated annual income and $7.25 in monthly estimated income. I started a position in Medical Properties Trust and Broadmark Realty Capital while adding to Altria Group and Clearway Energy.

Dividend Harvesting: Building The Portfolio Brick By Brick On $100 A Week, Week 14 Update

Altria stock is up 20% in the last six months and currently trades slightly below $50. Notwithstanding the fact that it belongs to the defensive tobacco sector, Altria stock has been able to clock impressive gains over the last few months on the back of several analysts marking an upward revision.

What's Next For Altria Stock After Its 20% Rally?

Under Armour

Wish

Altria and two other flawed stocks could offset your gains this year.

3 Stocks that Could Torpedo Your Portfolio

As the old adage goes, cheap stocks are cheap for a reason -- even if that measure of "cheap" is an unusually high dividend yield.

Altria's High Dividend Really Is Too Good to Be True

Kinder Morgan

ONEOK

Williams

Investors love dividend stocks because they not only provide dependable income but also give investors a great opportunity for solid total return.

The 5 Highest-Paying S&P 500 Dividend Stocks All Yield 5% or More

Apple

AbbVie

Abbott Labs

Blackrock Inc

Disney

Global X SuperDividend US ETF

Cohen & Steers Closed-End Opportunity Fund

Corning

Home Depot

Xtrackers USD High Yield Corporate Bond ETF

iShares International Select Dividend ETF

JPMorgan Chase & Co

Mastercard

Medtronic

Global X MLP ETF

Microsoft

NIKE

Realty Income Corp

Global X U.S. Preferred ETF

Prudential Financial

Invesco Nasdaq 100 ETF

iShares Mortgage Real Estate ETF

Starbucks

Schwab US Dividend Equity ETF

The portfolio provided $776 in dividend income during May. However, that amount was 15% lower than a year ago. I added shares to several existing holdings; ABT, DIS, WCLD, VPN, MSFT, AAPL, NKE, and O. I also added QQQM to the portfolio for a growth boost.

My Dividend Growth Portfolio May Update: 35 Holdings And 9 Buys

Altria's pricing power has helped to offset the secular decline in the cigarette industry. It has undertaken several initiatives to adapt to the changing customer preference and transform the product portfolio towards safer alternatives for cigarettes.

Altria: Moving Beyond Cigarettes

Following 2020's respective adjusted diluted EPS and FCF payout ratios of 77.5% and 77.1%, Altria Group's payout ratios are positioned to largely remain unchanged in 2021. While Altria Group's adjusted diluted EPS fell 1.8% YoY from Q1 2020 to Q1 2021, Altria Group beat analyst expectations by $0.02.

Altria Group: Reiterating My Buy Rating

Altria group offers a 7% dividend yield. The company has made several mistakes in the past several years.

Buy Altria For A Steady Decent Return

Altria faces risks from increasing industry regulation, their Juul investment and long-term uncertainty from tobacco's industry decline. But - Altria has a wide moat that will keep the company strong for years.

The Real Value Of Altria Stock

It's often important to look to the future when investing, and Altria's future is striving to be smoke-free. However, don't look too far or you might overlook a smokeable products business that continues to operate without much sign of slowing down.

See Through The Smoke, Altria's Smokeable Business Alone Makes It A Buy

At its current price and valuation, Altria Group (MO) represents a high risk and high return opportunity. The business faces regulatory risks surrounding the U.S. tobacco industry, litigation risks, a secular decline in demand, and as well as possible tax increases on tobacco products.

Altria Group - Perfect Setup For Long Call Option

The company posts yet another highly profitable quarter and pledges to maintain its high-yield dividend, but.

Altria's Q1: Is the Tobacco Giant All Smoke and No Flame?

Altria Group has superior profit and cash flow margins, but does not have large and growing international exposure. Philip Morris has the initiative over Altria Group in smoke-free products and looks more likely to transform its revenue mix earlier.

Altria Group And Philip Morris: The Battle Of The Tobacco Dividend Heavyweights

Altria Group, Inc. (NYSE: MO) shares have advanced more than 20% since the beginning of January 2021, and the current share price stands around $49.50. Altria is a stable company with a good position in the market, while its shares could be a good choice for any investor seeking secure dividend income.

Should you buy Altria Group shares in June?

Chevron

Iron Mountain

Lumen Technologies

MGM Growth Properties

So, which dividend stocks with relatively-safe high-yields should you consider? These nine remain relatively-safe income plays.

9 High-Yield Stocks With Little Risk of a Dividend Cut

Polaris

RenaissanceRe Hlds

SEI Investments

1st Source

Walgreens

The 8 Best Dividend Aristocrats You Can Buy With The Market At Record Highs

Aptiv

Concho Resources

Fiserv

Parker-Hannifin

Regeneron Pharmaceuticals

Bill Nygren (Trades, Portfolio), manager of the Oakmark Fund, disclosed this week that his firm's top six trades for the first quarter of 2021 included the closure of its positions in Aptiv PLC ( APTV , Financial) and Parker Hannifin Corp. ( PH , Financial), new stakes in Altria Group Inc. ( MO , Financial) and ConocoPhillips ( COP , Financial) and boosts to its holdings in Regeneron Pharmaceuticals Inc. ( REGN , Financial) and Fiserv Inc. ( FISV , Financial).

Bill Nygren's Top 6 Trades in the 1st Quarter

News for Altria Stock (MO)